XML 108 R89.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:        
Cash and cash equivalents $ 25,312 $ 25,427    
Total current assets 85,779 78,437    
Other assets 19,590 17,298    
Total assets 298,278 273,720 $ 245,705  
Current liabilities:        
Accounts payable and accrued liabilities 34,337 31,958    
Total current liabilities 103,769 99,054    
Long-term debt, less current maturities 72,359 58,263    
Other liabilities 15,939 14,463    
Total liabilities 195,687 174,801    
Commitments and contingencies (Note 4)    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 915 and 924 issued and outstanding 9 9    
Retained earnings 96,036 95,774    
Accumulated other comprehensive loss (3,387) (7,027)    
Total liabilities and shareholders’ equity 298,278 273,720    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 234 776 $ 266 $ 2,167
Other current assets 411 570    
Total current assets 645 1,346    
Equity in net assets of subsidiaries 179,209 153,692    
Other assets 920 831    
Total assets 186,836 161,562    
Current liabilities:        
Accounts payable and accrued liabilities 1,501 1,116    
Short-term notes payable to subsidiaries 2,000 9,900    
Short-term borrowings and current maturities of long-term debt 4,348 4,086    
Total current liabilities 7,865 15,089    
Long-term debt, less current maturities 71,831 57,387    
Long-term notes payable to subsidiaries 14,400      
Other liabilities 77 330    
Total liabilities 94,178 72,806    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 915 and 924 issued and outstanding 9 9    
Retained earnings 96,036 95,774    
Accumulated other comprehensive loss (3,387) (7,027)    
Total UnitedHealth Group shareholders’ equity 92,658 88,756    
Total liabilities and shareholders’ equity 186,836 161,562    
Parent Company [Member] | Subsidiaries [Member]        
Current assets:        
Long-term notes receivable from subsidiaries 6,062 5,693    
Current liabilities:        
Short-term notes payable to subsidiaries 2,016 9,887    
Long-term notes payable to subsidiaries $ 14,405 $ 0